Today’s drug manufacturing by the pharmaceutical industry are exposed to
numerous risks and challenges evolving round consumer satisfaction, consumer
education and consumer rights; this challenges no doubt emanates from the
companies quest to cope with the constant industry change, competitive
pressures, increased governance, and the uncertainties involved in research and
development to bring new products to market.
In all these, pharmaceutical companies are faced with
the daunting task of researches to produce drugs for their consumers, as well
as develop its products to stay in business and convince consumers that they
are the best in the market.
The process of drug manufacturing and production starts
from the point of conceiving an innovation to researching and conducting
clinical trials of the drugs before the products can be finalized for production.
The chunk of consumer dissatisfaction and consumer
rights infringement starts from the point of research, production and
distribution; it has being observed that drug market place gets its
root from research, but research anchored on consumer satisfaction helps to
correct unplanned violations in the chain of production and distribution.
Liabilities of drug defects and drugs that causes
damage to human health rather than improve is premised on the fact that content
are not measured for consumer satisfaction, but rather centered on profits
making.
Drug manufacturing in Nigeria will have more value in
the international markets if research, clinical trials and manufacturing is
developed not only on the foundation of
science and formulas, but should as well extend to the scientist asking
questions and researching on the strategies and platform to ensure that
consumers gets its best satisfaction if a drug or pharmaceutical product is
released into the market.
OSUYA & OSUYA LAW FIRM
No comments:
Post a Comment